Product Images Adempas
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 16 images provide visual information about the product associated with Adempas NDC 50419-254 by Bayer Healthcare Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text appears to be a list of medications and substances, along with recommendations for potential interactions with other drugs or supplements. The list includes various strong and moderate inhibitors and inducers, as well as antacids, antiplatelet agents, and more. The specific details of the recommendations are difficult to decipher without further context, but it appears that some medications may require dose adjustments or separate administration to avoid potential negative interactions.*
Adempas is a medication that comes in tablet form, containing Riociguat. The dosage should be strictly followed, and it needs to be stored at 25 degree Celsius. It is a prescription drug, and the details about the drug, such as composition and storage, are provided on the carton. The provided text contains some distortion; might have not read it correctly.*
This is a description of a medication called Adempas, which comes in tablet form. The tablets are available in a strength of 2mg per tablet and are embossed with the code "PR S2277060". The medication contains riociguat and is used to treat pulmonary arterial hypertension. The label on the packaging mentions that the tablets are varnish-free, but there is no information available on what this means.*
This text contains information on a medicine called Adempas (riociguat) tablets. Each container has 30 soluble tablets, containing 25 mg of riociguat per tablet. The recommended dosage is to take one tablet three times daily. Storage instructions advise keeping the medicine at room temperature (25-77 F) and protecting it from light. The text also includes various product codes and references to a "VARNISH FREE" feature, but it is unclear how this relates to the medicine itself.*
This seems to be a table or chart depicting the change in 6-minute walk distance in some sort of study or experiment. The text also includes the words "Improvement" and "Worsening" which likely indicate the direction of change in the participants' walking ability. However, the rest of the text appears to be a mix of letters, numbers, and symbols that cannot be interpreted as readable language.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.